PESCARMONA, Gianpiero

PESCARMONA, Gianpiero  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 142 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. 1992 CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A
A culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related thereto 2007 GENNERO L; PONZETTO A; DE VIVO E; CONTU L; MORRA E; CESANO C; CAVALLO G; CICERO G; PESCARMONA GP; DENYSENKO T; ROOS MA; SARA M
A Dedicated Image Analysis Software Tool for the Evaluation of the Resorption Activity of Cultured Osteoclasts 2008 BRIANZA S.Z.M; D'AMELIO P.; CERRATO M; BIGNARDI C; GRIMALDI A; PESCARMONA G.P; ISAIA G
A physical-based model for the simulation of neoplastic growth and metastasis. 2000 MAGNANO M.; BONGIOANNINI G.; LERDA W.; GALVAGNO MB.; TONDOLO E.; CANALE G.; CAPOGROSSO B.; DELSANTO PP.; SCALERANDI M.; G. PESCARMONA
A simplified method for the pentose phosphate pathway assay in red cells. 1982 PESCARMONA GP ;BOSIA A ;ARESE P ;SARTORI ML ;GHIGO D
Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 1988 F. BUSSOLINO; G. PESCARMONA; G. CAMUSSI; F. GREMO
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 1995 HELLER R ;BUSSOLINO F ;GHIGO D ;PESCARMONA GP ;CALVINO R ;GASCO A ;TILL U ;BOSIA A
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells 2008 Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. 2001 MARTINA V; BRUNO GA; ZUMPANO E; ORIGLIA C; QUARANTA L; GP. PESCARMONA
Alendronate reduces osteoclast precursors in osteoporosis 2010 P D’Amelio; A Grimaldi; MA Cristofaro; M Ravazzoli; PA Molinatti; GP Pescarmona; G Isaia
Analysis and Prototyping of Biological Systems 2005 DI LEVA A; BERCHI R; PESCARMONA G.; SONNESSA M
Analysis and Prototyping of Biological Systems: the Abstract Biological Process Model 2005 DI LEVA A; BERCHI R; PESCARMONA G.; SONNESSA M
Analysis of a 'phase transition' from tumor growth to latency. 2000 DELSANTO PP; ROMANO A; SCALERANDI M; G. PESCARMONA
The analysis of glutamate and glutamine frequencies in human proteins as marker of tissue oxygenation 2019 Vernone A.; Ricca C.; Merlo D.; Pescarmona G.; Silvagno F.
Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer 2010 Silvagno F; Poma CB; Realmuto C; Ravarino N; Ramella A; Santoro N; D'Amelio P; Fuso L; Pescarmona G; Zola P
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression 2009 Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition 2007 RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A
Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures 2011 D’Amelio P; Roato I; D’Amico L; Veneziano L; Suman E; Sassi F; Bisignano G; Ferracini R; Gargiulo G; Castoldi F; Pescarmona GP; Isaia GC.
Calcium blood level modulates endogenous nitric oxide action: effects of parathroidectomy in patients with hyperparathyroidism. 1998 MARTINA V.; BRUNO G. A.; BRANCALEONI V.; ZUMPANO E.; TAGLIABUE M.; FORNENGO R.; GASPARRI G.; G. PESCARMONA
Cardiac glycosides as new modulators of cholesterol metabolism 2012 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti